IMCR
Immunocore Holdings PLC - ADR

518
Mkt Cap
$1.82B
Volume
53,202.00
52W High
$40.71
52W Low
$23.15
PE Ratio
-61.67
IMCR Fundamentals
Price
$35.96
Prev Close
$36.03
Open
$35.99
50D MA
$35.15
Beta
0.76
Avg. Volume
325,381.11
EPS (Annual)
-$1.02
P/B
4.61
Rev/Employee
$629,477.75
Loading...
Loading...
News
all
press releases
Immunocore (NASDAQ:IMCR) Reaches New 1-Year High - Here's What Happened
Immunocore (NASDAQ:IMCR) Reaches New 1-Year High - Time to Buy...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Immunocore (NASDAQ:IMCR) Sets New 1-Year High - Still a Buy?
Immunocore (NASDAQ:IMCR) Reaches New 1-Year High - Here's Why...
MarketBeat·14d ago
News Placeholder
Immunocore (NASDAQ:IMCR) Reaches New 52-Week High - What's Next?
Immunocore (NASDAQ:IMCR) Hits New 52-Week High - What's Next...
MarketBeat·20d ago
News Placeholder
Fiera Capital Corp Purchases 7,924 Shares of Immunocore Holdings PLC Sponsored ADR $IMCR
Fiera Capital Corp lifted its holdings in Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR - Free Report) by 1.0% in the second quarter, according to the company in its most recent disclosure with...
MarketBeat·26d ago
News Placeholder
Fox Run Management L.L.C. Invests $372,000 in Immunocore Holdings PLC Sponsored ADR $IMCR
Fox Run Management L.L.C. purchased a new stake in Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR - Free Report) in the second quarter, according to its most recent filing with the SEC. The fund...
MarketBeat·27d ago
News Placeholder
Immunocore (NASDAQ:IMCR) Price Target Raised to $36.00 at Morgan Stanley
Morgan Stanley upped their price target on shares of Immunocore from $34.00 to $36.00 and gave the stock an "equal weight" rating in a research report on Monday...
MarketBeat·30d ago
News Placeholder
Immunocore (NASDAQ:IMCR) Announces Earnings Results
Immunocore (NASDAQ:IMCR - Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.02 earnings per share for the quarter, beating the consensus estimate of ($0.30) by...
MarketBeat·1mo ago
News Placeholder
Immunocore (IMCR) Reports Q3 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Immunocore (IMCR) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·1mo ago
News Placeholder
Recursion Pharmaceuticals to Report Q3 Earnings: What's in the Cards?
RXRX gears up for Q3 results as it refocuses its pipeline and collaboration-driven revenue strategy.
Zacks·1mo ago
News Placeholder
IOVA Q2 Earnings Miss, Stock Down on EMA Filing Withdrawal for Amtagvi
Iovance shares plunge after Q2 miss and voluntary withdrawal of Amtagvi's EU filing, despite strong U.S. sales growth for the therapy.
Zacks·4mo ago

Latest IMCR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.